Anti-Human C5 Recombinant Antibody(Ravulizumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human C5 Recombinant Antibody(Ravulizumab)

Anti-Human C5 Recombinant Antibody(Ravulizumab)

产品编号

YR1443

别名

科研级 Ravulizumab ( 雷夫利珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Ravulizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Ravulizumab ( 雷夫利珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Ravulizumab
Catalog Number	YR1443
Molecular Name	Ravulizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2-G4 Kappa
Formulation	PBS, pH7.5
Background	Ravulizumab, sold under the brand name Ultomiris, is a humanized monoclonal antibody complement inhibitor medication designed for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. It is designed to bind to and prevent the activation of Complement component 5 (C5).
CAS Number	1803171-55-2
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	C5[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0